Introduction: in adults, adenomas are the most frequent causes of pituitary tumours. The objective was to characterize its epidemiological and clinical aspects, as well as its therapeutic modalities in Senegal. Methodology: this was a multicenter, retrospective, descriptive and analytical study carried out from the Senegalese register of pituitary adenomas (2008-2022). Results: 242 patients were collected with an average age of 42.4 ± 13 years and a sex ratio (M/F) of 0.91. The mean consultation time was 19.7 ± 23 months. The circumstances of discovery were pituitary apoplexy (11 cases, 4.54%), tumor syndrome (176 cases, 72.72%), gonadal manifestations (103 cases, 42.56%), dysmorphic syndrome (21 cases, 8.68%), hypercorticism (15 cases, 6.19%). Morphologically, it was a macroadenoma (197 cases, 81.40%), an extensive adenoma (22 cases, 9.10%). The hormonal profile was lactotropic hypersecretion (80 cases, 33.05%), somatotropic (13 cases, 5.39%), corticotropic (14 cases, 5.78%), mixed (9 cases, 3.71%). The factors significantly associated with prolactinoma were young age (p = 0.000), female sex (p = 0.000), long consultation delay (p = 0.000) and microadenoma (p = 0.001). Only arterial hypertension was associated with acromegaly (p = 0.000). We found a significant correlation between Cushing’s disease and microadenomas (p = 0.000). Non-secreting adenomas were significantly associated with advanced age (p = 0.000), long delay in consultation (p = 0.000), male gender (p = 0.000), tumor syndrome (p = 0.001) and macroadenomas (p = 0.000). Pituitary surgery was effective in 173 patients (71.49%) including 166 cases (68.59%) by transphenoidal approach. Postoperative incidents were transient diabetes insipidus in 82 cases (47.39%), cerebrospinal fluid leak (20 cases, 11.56%). Death was observed in 18 patients in the entire series (7.44%). The latter had a tumor syndrome (88.88%), a macroadenoma (83.33%) and had undergone pituitary surgery (72.22%). Conclusion: pituitary pathology has become a reality with clinical and secretory polymorphism. The diagnostic delay explains the predominance of macroadenomas which are sources of pre and post-operative complications.
Buchfelder, M. and Fahlbusch, R. (2002) The “Classic” Transsphenoidal Approach for Resection of Pituitary Tumors. Operative Techniques in Neurosurgery, 5, 210-217. https://doi.org/10.1053/otns.2002.32498
González-González, J.L., López-Arbolay, O., Morales-Sabina, O., Martí-Piñeiro, J.F. and Vidal-Verdial, R. (2005) Transnasal-Transsphenoidal Endoscopic Surgery of the Sellar Región. Neurocirugía, 16, 27-33. https://doi.org/10.1016/S1130-1473(05)70431-0
Eloundou, N.J., Eyenga, V.C., Ngowe, M., Atangana, R. and Sosso, M.A. (2009) Pituitary Adenomas. Study of a Surgical Series of 16 Cases in Yaoundé Cameroon. African Journal of Neurological Sciences, 28, 55-60.
Fontana, E. and Gaillard, R. (2009) Epidemiology of Pituitary Adenoma: Results of the First Swiss Study. Revue Médicale Suisse, 5, 2171-2174. (In French)
Irfan, H., Shafiq, W., Siddiqi, A.I., et al. (2022) Prolactinoma: Clinical Characteristics, Management and Outcome. Cureus, 14, e29822. https://doi.org/10.7759/cureus.29822
Kars, M., Dekkers, O.M., Pereira, A.M. and Romijn, J.A. (2010) Update in Prolactinomas. Netherlands Journal of Medicine, 68, 104-112.
Mosbah, H., Brue, T. and Chanson, P. (2019) Acromegaly: Improving Care. Annals of Endocrinology, 80, S10-S18. https://doi.org/10.1016/S0003-4266(19)30112-X
El Habnouny, J., Assarrar, I., Berrabeh, S., Rouf, S. and Latrech, H. (2020) Pituitary Adenomas: Epidemiological, Clinical, Biological, Radiological and Therapeutic Aspects at the CHU Mohammed VI in Oujda. Annals of Endocrinology, 81, 294. (In French) https://doi.org/10.1016/j.ando.2020.07.418
Guiot, G., Thibaut, B. and Bourreau, M. (1959) Extirpation of Hypophyseal Adenomas by Trans-Septal and Trans-Sphenoidal Approaches. Ann Otolaryngol., 76, 1017-1031. (In French)
Hardy, J. (1969) Transphenoidal Microsurgery of the Normal and Pathological Pituitary. Neurosurgery, 16, 185-217. https://doi.org/10.1093/neurosurgery/16.CN_suppl_1.185
Daly, A.F. and Beckers, A. (2020) The Epidemiology of Pituitary Adenomas. Endocrinology and Metabolism Clinics of North America, 49, 347-355. https://doi.org/10.1016/j.ecl.2020.04.002
Chen, C., Hu, Y., Lyu, L., Yin, S., Yu, Y., Jiang, S., et al. (2021) Incidence, Demographics, and Survival of Patients with Primary Pituitary Tumors: A Seer Database Study in 2004-2016. Scientific Reports, 11, Article No. 15155. https://doi.org/10.1038/s41598-021-94658-8
Hima-Maiga, A., Fomekong, E., Vaz, G., Kelani, A., Abdoulwahab, I., Gaye, M., et al. (2021) Giant Pituitary Adenomas and Visual Disorders at Saint-Luc Clinics (Brussels): Meaning and Evolution apropos of 22 Cases. Health Sciences and Disease, 22, 38-43.
Abodo, J., Haidara, A., Koffi Dago, P., Kouassi, F., Hué, L.A. and Lokrou, A. (2016) [Profile of Pituitary Adenomas in Sub-Saharan Africa Apropos of 38 Cases]. Annals of Endocrinology, 77, 368-369. (In French) https://doi.org/10.1016/j.ando.2016.07.381
Fernandez, A., Karavitaki, N. and Wass, J.A.H. (2010) Prevalence of Pituitary Adenomas: A Community-Based, Cross-Sectional Study in Banbury (Oxfordshire, UK). Clinical Endocrinology, 72, 377-382. https://doi.org/10.1111/j.1365-2265.2009.03667.x
Daly, A.F., Rixhon, M., Adam, C., et al. (2006) High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liège, Belgium. The Journal of Clinical Endocrinology & Metabolism, 91, 4769-4775. https://doi.org/10.1210/jc.2006-1668
Salami, A., Malomo, A.O., Shokunbi, T. and Akang, E. (2013) Immunohistochemical Analysis of Pituitary Adenomas in a West African Hospital. African Journal of Neurological Sciences, 32, 72-80.
Schaller, B. (2002) Gender-Related Differences in Growth Hormone-Releasing Pituitary Adenomas. A Clinicopathological Study. Pituitary, 5, 247-253. https://doi.org/10.1023/A:1025329900839
Mayanda, O.R.L., Ignaleamoko, T.G.S.P., Ekouele, M.H.B., et al. (2021) Management of Prolactin Pituitary Adenomas at the Brazzaville University and Hospital Center. Health Sciences and Disease, 22, 68-73.
Neggers, S.J., van Aken, M.O., Janssen, J.A., Feelders, R.A., de Herder, W.W. and van der Lely, A.J. (2007) Long-Term Efficacy and Safety of Combined Treatment of Somatostatin Analogs and Pegvisomant in Acromegaly. The Journal of Clinical Endocrinology & Metabolism, 92, 459-8601. https://doi.org/10.1210/jc.2007-1234
Bertagna, X. and Guignat, L. (2012) Recent Progress in the Treatment of Cushing’s Disease. Annals of Endocrinology, 73, 107-110. (In French) https://doi.org/10.1016/j.ando.2012.03.036
Espinosa, E., Sosa, E., Mendoza, V., et al. (2016) Giant Prolactinomas: Are They Really Different from Ordinary Macroprolactinomas? Endocrine, 52, 652-659. https://doi.org/10.1007/s12020-015-0791-7
Colao, A., Vitale, G., Cappabianca, P., et al. (2004) Outcome of Cabergoline in Men with Prolactinoma: Effects of a 24-Mounth Treatment on Prolactin Levels, Tumor Mass, Recovery of Pituitary Function, and Semen Analysis. The Journal of Clinical Endocrinology & Metabolism, 89, 1704-1711. https://doi.org/10.1210/jc.2003-030979
Elfelehm E., Bchirm N., Rojbim I,m et al. (2016) Evolution of Macroprolactinomas under Medical Treatment. Annals of Endocrinology, 77, 329-371. (In French) https://doi.org/10.1016/j.ando.2016.07.270
Trévillot, V., Lassave, J., Cartier, C., et al. (2012) Endonasal Endoscopic Pituitary Surgery: About 121 Cases. French Annals of Otorhinolaryngology and Cervico-Facial Pathology, 129, 69-70. (In French) https://doi.org/10.1016/j.aforl.2012.07.184
Kassis, S., De Battista, J.C., Raverot, G., et al. (2009) [Endoscopy versus Microsurgery: Results in a Consecutive Series of Nonfunctioning Pituitary Adenomas]. Neurosurgery, 55, 607-615. (In French) https://doi.org/10.1016/j.neuchi.2009.05.003
Baldé, N.M., Ben Yaya, M., Poirier, J.Y., et al. (2005) Long-Term Prognosis of Non-Functional Pituitary Adenomas Operated on via the Transsphenoidal Approach. Annals of Endocrinology, 67, 416 p. (In French)
Sigounas, D.G., Sharpless, J.L., Cheng, D.M., Johnson, T.G., Senior, B.A. and Ewend, M.G. (2008) Predictors and Incidence of Central Diabetes Insipidus after Endoscopic Pituitary Surgery. Neurosurgery, 62, 71-79. https://doi.org/10.1227/01.NEU.0000311063.10745.D8